INS and type 1 diabetes mellitus: A pilot study with the administration ofGAD-alum in the inguinal lymph node and VIT D (2,000 IU/day) in 12 newly diagnosedpatients with stage 3 T1D led to the maintenance of C-peptide, improved glycemic controland reduction in insulin dose after 15 months (73).